BIOMERICA INC APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition
BIOMERICA INC (BMRA) reported APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition of $1.26 million for the 12-month period ending 2022-05-31, per its 10-K filed 2022-08-29.
Discontinued › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition · last filed 2022-08-29
- BIOMERICA INC apic, share-based payment arrangement, option, increase for cost recognition for the quarter ending 2021-11-30 was $314.40K, a 24.09% increase year-over-year.
- BIOMERICA INC apic, share-based payment arrangement, option, increase for cost recognition for the quarter ending 2021-08-31 was $319.62K, a 29.51% increase year-over-year.
- BIOMERICA INC apic, share-based payment arrangement, option, increase for cost recognition for the quarter ending 2021-05-31 was $1.09M, a 216.32% increase year-over-year.
- BIOMERICA INC apic, share-based payment arrangement, option, increase for cost recognition for the quarter ending 2021-02-28 was -$238.96K, a 251.30% decline year-over-year.
- BIOMERICA INC apic, share-based payment arrangement, option, increase for cost recognition for fiscal 2022 was $1.26M, a 6.97% decline from fiscal 2021.
- BIOMERICA INC apic, share-based payment arrangement, option, increase for cost recognition for fiscal 2021 was $1.35M, a 151.51% increase from fiscal 2020.
- BIOMERICA INC apic, share-based payment arrangement, option, increase for cost recognition for fiscal 2020 was $538.59K, a 256.15% increase from fiscal 2019.
- BIOMERICA INC apic, share-based payment arrangement, option, increase for cost recognition for fiscal 2019 was $151.22K, a 718.62% increase from fiscal 2018.
| Period end | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 3 month as first filed | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 6 month as first filed | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 12 month | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2022-05-31 | $1.26M 10-K · filed 2022-08-29 | ||||||
| 2021-11-30 | $314.40K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-01-12 | $634.02K 10-Q · filed 2022-01-12 | $1.73M derived: sum of 3 quarters · filed 2022-08-29 | $1.49M derived: sum of 4 quarters · filed 2022-08-29 | |||
| 2021-08-31 | $319.62K 10-Q · filed 2021-10-14 | $1.41M derived: sum of 2 quarters · filed 2022-08-29 | $1.17M derived: sum of 3 quarters · filed 2022-08-29 | $1.43M derived: sum of 4 quarters · filed 2022-08-29 | |||
| 2021-05-31 | $1.09M derived: 10-K 12 month − 10-Q 9 month · filed 2022-08-29 | $854.47K derived: sum of 2 quarters · filed 2022-08-29 | $1.11M derived: sum of 3 quarters · filed 2022-08-29 | $1.35M 10-K · filed 2022-08-29 | $377.39K 10-K · filed 2021-08-27 | ||
| 2021-02-28 | -$238.96K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-04-14 | $14.39K derived: sum of 2 quarters · filed 2022-01-12 | $261.18K 10-Q · filed 2021-04-14 | $606.85K derived: sum of 4 quarters · filed 2022-01-12 | |||
| 2020-11-30 | $253.35K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-01-12 | $500.14K 10-Q · filed 2022-01-12 | $24.23K 10-Q · filed 2021-01-14 | $845.81K derived: sum of 3 quarters · filed 2022-01-12 | $1.00M derived: sum of 4 quarters · filed 2022-01-12 | ||
| 2020-08-31 | $246.79K 10-Q · filed 2021-10-14 | $3.81K 10-Q · filed 2020-10-15 | $592.46K derived: sum of 2 quarters · filed 2021-10-14 | $750.40K derived: sum of 3 quarters · filed 2021-10-14 | $779.52K derived: sum of 4 quarters · filed 2021-10-14 | ||
| 2020-05-31 | $345.67K derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-10-14 | $503.61K derived: sum of 2 quarters · filed 2021-10-14 | $532.74K derived: sum of 3 quarters · filed 2021-10-14 | $538.59K 10-K/A · filed 2021-10-14 | $200.47K 10-K · filed 2020-08-31 | ||
| 2020-02-29 | $157.94K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-04-14 | $187.07K derived: sum of 2 quarters · filed 2021-04-14 | $192.92K 10-Q · filed 2021-04-14 | $197.63K derived: sum of 4 quarters · filed 2021-04-14 | |||
| 2019-11-30 | $29.13K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-01-14 | $34.98K 10-Q · filed 2020-01-14 | $39.69K derived: sum of 3 quarters · filed 2020-08-31 | ||||
| 2019-08-31 | $5.85K 10-Q · filed 2019-10-15 | $10.56K derived: sum of 2 quarters · filed 2020-08-31 | |||||
| 2019-05-31 | $4.71K derived: 10-K 12 month − 10-Q 9 month · filed 2020-08-31 | $151.22K 10-K · filed 2020-08-31 | |||||
| 2019-02-28 | $146.51K 10-Q · filed 2019-04-15 | ||||||
| 2018-05-31 | $18.47K 10-K · filed 2019-08-29 | ||||||
| 2017-05-31 | $21.73K 10-K · filed 2018-08-29 | ||||||
| 2016-05-31 | $15.15K 10-K · filed 2017-08-29 | ||||||
| 2015-05-31 | $10.02K 10-K · filed 2016-08-29 | ||||||
| 2014-05-31 | $11.00K 10-K · filed 2015-08-31 | ||||||
| 2013-05-31 | $20.86K 10-K · filed 2014-08-29 | ||||||
| 2012-05-31 | $53.62K 10-K · filed 2013-08-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |